On Tuesday, September 15, 2026, from 1:00 PM JST, our CEO/CSO Satoshi Tamaki will take the stage as a finalist at Innovation Tiger 2026, a pitch event hosted by Shonan Health Innovation Park (Shonan iPark).

Innovation Tiger is a pitch competition for Asian drug discovery startups and academic teams with outstanding seeds and strong potential. MOLCURE was selected as a finalist from 89 applicants across Japan, South Korea, and Taiwan. Judges from major pharmaceutical companies and U.S.-based venture capital firms will evaluate the pitches. Through this pitch, MOLCURE will present its drug discovery technology and business development to pharmaceutical companies and investors in Japan and abroad, engaging in dialogue toward future business partnerships.

The event will be conducted in Japanese. For more details and advance registration, please see the official press release.